Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.
Learn MoreTranscriptomics has revolutionized cancer research by providing a comprehensive understanding of gene expression patterns in cancer cells. Alfa Cytology, a leading preclinical contract research organization (CRO), specializing in advanced biological research, offers comprehensive transcriptomics services specifically designed for cancer research.
Transcriptomics involves the study of the complete set of RNA transcripts produced by the genome under specific circumstances or in a specific cell population. This includes messenger RNA (mRNA), non-coding RNA (such as microRNAs), and other regulatory RNA molecules.
In cancer research, transcriptomics is used to identify changes in gene expression that contribute to cancer phenotype, the effects of genetic mutations and the therapeutic response. The current focus in transcriptomics research is not only to catalog the gene expression changes associated with different types of cancers but also to understand how these changes contribute to disease progression and resistance to therapy.
At Alfa Cytology, we offer comprehensive transcriptomics services tailored specifically for cancer research. With state-of-the-art technologies and a team of expert scientists, we provide high-quality data and in-depth analysis to advance our understanding of cancer biology.
Our services encompass sample preparation, sequencing, data analysis, and interpretation, ensuring a seamless and robust workflow. Our services include, but are not limited to:
Service Options | Description |
Whole Transcriptome Sequencing (RNA-Seq) | We provide comprehensive analysis of all RNA transcripts present in a sample to give a complete picture of gene expression. |
Targeted RNA Sequencing | Focused on specific genes or transcripts of interest, this service is suitable for detailed studies and follow-up experiments. |
Non-coding RNA Profiling | We identify and analyze non-coding RNAs, such as miRNA and lncRNA, which play crucial roles in regulating gene expression in cancer. |
Quantitative Real-Time PCR (qPCR) | For validation of RNA-Seq results, we offer qPCR services with high precision and accuracy. |
Sample Collection and Preparation
We guide researchers in sample collection, preservation, and RNA extraction to ensure high-quality data output.
Library Preparation and Sequencing
We employ state-of-the-art library preparation protocols and sequencing platforms to generate high-resolution transcriptomic data.
Data Analysis and Interpretation
Our bioinformatics team performs rigorous data analysis, including quality control, alignment, normalization, differential gene expression analysis, and pathway enrichment analysis.
Comprehensive Report
We provide detailed reports summarizing the results, along with expert interpretation and guidance for further research.
With expertise in sample preparation, next-generation sequencing, data analysis, and integration with other omics data, Alfa Cytology empowers researchers to unravel the molecular mechanisms of cancer and identify potential therapeutic targets. If you are interested in our service, please contact us for more details.
For research use only.